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Some animal studies and some human studies suggest that exposure to 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) may be associated with adverse effects on the cardiovascular
system. As part of a cross-sectional medical study comparing workers employed 15 years earlier
in the manufacture of 2,4,5-trichlorophenol or one of its derivatives at two U.S. chemical plants
with an unexposed comparison group, we examined the association between TCDD exposure
and various cardiovascular outcomes. A total of 281 workers and 260 unexposed referents
participated. The workers had substantial exposure to TCDD, as demonstrated by significantly
elevated mean serum TCDD concentration of 220 pg/g of lipid, compared with 7 pg/g of lipid
among the referents. No significant association was found between TCDD exposure and any of
the cardiovascular outcomes including myocardial infarction, angina, cardiac arrhythmias,
hypertension, and abnormal peripheral arterial flow. Although our study had sufficient statistical
power to detect an elevated risk for cardiac arrhythmias, hypertension, and abnormal peripheral
arterial flow, it had low power (approximately 50%) to detect an elevated risk for myocardial
infarction and angina. Our review of the literature suggests that our negative findings are
consistent with those from other cross-sectional medical studies. Although several mortality
studies of TCDD-exposed cohorts found significantly increased risks for cardiovascular disease
mortality, similar increased risks were not observed in other mortality studies. The data available
do not provide definitive conclusions but indicate that further examination of the association
between TCDD exposure and cardiovascular disease should be pursued. Environ Health
Perspect 106(Suppl 2):635-643 (1998). http://ehpnetl.niehs.nih.gov/docs/1998/Suppl-2/
635-643calvert/abstract.html
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Introduction
Dioxins are produced as unwanted continues to be widespread. Among the
contaminants during the combustion or health concerns is cardiovascular toxicity.
production of chlorinated compounds. Animal studies indicate that exposure to
2,3,7,8-Tetrachlorodibenzo-p-dioxin high doses ofTCDD can produce effects
(TCDD) is considered the most toxic ofthe on the cardiovascular system. These effects
dioxin congeners. Concern about the toxic- include ventricular dilatation (1), cardiac
ity of this and other dioxinlike congeners edema (1,2), valvulitis (2), myocardial
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degeneration (3), preatherosclerotic
lesions in the aorta (4), and altered cardiac
contractility (5-8).
Evidence for TCDD effects on the
cardiovascular system in humans is con-
flicting. Case reports ofTCDD-exposed
individuals have described myocarditis (9),
myocardial infarctions (10,11), ectasia of
the coronary arteries (12), and rapidly pro-
gressive atherosclerosis (13,14). Four mor-
tality studies ofTCDD-exposed cohorts
reported significantly elevated risks for car-
diovascular disease mortality (15-18),
whereas several others have not observed
such elevations (19-22). Although several
cross-sectional medical studies have also
examined the association between TCDD
exposure and effects on the cardiovascular
system (23-27), statistically significant
associations were found only in the study
of U.S. Air Force Ranch Hand personnel
responsible for spraying TCDD-contami-
nated Agent Orange in Vietnam (27). The
Ranch Hands Study found statistically sig-
nificant associations between TCDD expo-
sure and peripheral pulse abnormalities of
several arteries, medical record-verified
hypertension, and one type of electrocar-
diogram (ECG) abnormality. In addition,
findings from cross-sectional medical
studies suggest that TCDD exposure may
be associated with several risk factors for
cardiovascular disease, including disorders
oflipid metabolism (27-29), and glucose
intolerance (30).
In this paperwe report the cardiovascular
findings from the largest cross-sectional
morbidity study of TCDD-exposed
industrial workers. These workers formerly
were involved in production of 2,4,5-
trichlorophenol (TCP) or one ofits deriva-
tives. Data were collected and analyzed to
determine ifTCDD exposure is associated
with an increased risk for myocardial
infarction, angina, cardiac arrhythmia,
hypertension, and abnormal peripheral
arterial flow.
Materials and Methods
In 1987, a cross-sectional medical study
was undertaken to examine the long-term
health effects of occupational exposure to
chemicals and materials contaminated
with TCDD. Details of the study design
have been previously described (31). In
summary, this study compared living
individuals (workers) employed more
than 15 years earlier in the production of
TCP or one of its derivatives, which were
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substances contaminated with TCDD,
with an unexposed comparison group. The
workers were employed in one of two
plants in Newark, NewJersey, and Verona,
Missouri. Four hundred ninety workers
were employed at the New Jersey facility
from 1951 through 1969 in the produc-
tion ofTCP or one of its derivatives. At
the facility in Verona, Missouri, 96 indi-
viduals were involved in the production of
TCP or one of its derivatives. Production
took place for approximately 4 months in
1968 and from April 1970 to January
1972. Both plants produced a variety of
other chemicals, none ofwhich are known
or suspected cardiotoxins. To constitute
the referent (comparison) group, one indi-
vidual with no self-reported occupational
exposure to TCDD-contaminated sub-
stances was sought from within the resi-
dential neighborhood ofeach worker; this
individual matched the worker in age
(within 5 years), race, and gender. The
study protocol was approved by the
National Institute for Occupational Safety
and Health Human Subjects Review Board
and informed consent was obtained from
each ofthe participants.
Information on worker and referent
health status was collected through a com-
prehensive set ofstandardized interviews
and medical examinations. A lifetime med-
ical history was elicited from each partici-
pant using interviewer-administered
questionnaires. To reduce observer bias, all
individuals conducting the medical histo-
ries, examinations, and tests were blind to
the exposure status (worker or referent) of
the participant. An interviewer-adminis-
tered lifetime occupational history was
elicited from each participant separate from
the medical history. Duration ofeach job
and length ofoccupational exposure to spe-
cific substances were recorded beginning
with the participant's 16th birthday.
Bloodwas obtained from theparticipants
after fasting and analyzed for TCDD (32),
total cholesterol, triglyceride, high-density
lipoprotein (HDL) cholesterol, and glucose.
Two participants (one worker and one
referent) did nothave their blood drawn.
The medical examination consisted of
a general physical examination (includ-
ing blood pressure measurement in each
arm while the participant was seated),
Doppler examination of the peripheral
pulses, chest X-ray, and ECG (Marquette
Microcomputer Augmented Cardiograph
II (Marquette Electronics, Milwaukee,
WI). The computer interpretations of
the ECG were reviewed blindly by
board-certified cardiologists, who made
corrections where appropriate.
The Doppler examination of the
peripheral pulses involved measuring of
ankle and arm pressures using a standard
Baumonometer blood pressure bag and cuff
and a Doppler ultrasonic instrument
(Model 1010-LA, Parks Medical Elec-
tronics, Aloha, OR) while the participant
was supine. The examination was divided
into two parts: resting examination and
postocclusion examination.
The resting examination involved
bilateral blood pressure measurement at
the brachial artery (arm blood pressure)
and at the ankle (either the posterior tibial
artery or the dorsalis pedis artery). The
postocclusion examination involved inflat-
ing blood pressure cuffs that were placed
around the participant's calves bilaterally
to a pressure approximately 50 mm Hg
higher than the maximal brachial pressure.
After 5 min, both cuffs were deflated
simultaneously and ankle blood pressures
were measured bilaterally at both 1 and 2
min postocclusion. Generally, the dorsalis
pedis artery blood pressure was measured
at resting and postocclusion rather than
the posterior tibial because of the dorsalis
pedis ease of measurement. Measurement
ofthe brachial blood pressure was repeated
3 min postocclusion.
Normally, ankle blood pressure should
equal or slightly exceed arm blood pressure
(33). The resting index has been derived to
represent this relationship and was calcu-
lated by dividing the resting ankle pressure
by the maximal resting brachial pressure. A
resting index value of0.97 or greater is con-
sidered normal. A value less than 0.97 is
consistent with abnormal peripheral arterial
flow (APAF) (33).
Because the resting index may not
detect all cases ofAPAF, the postocclusion
exam was included in our study. Including
the postocclusion exam increases the sensi-
tivity ofdetecting APAF (33). Normally,
the ankle blood pressure at 1 min post-
occlusion should equal or slightly exceed
the arm blood pressure. The recovery
indices have been derived to represent this
relationship. The recovery index 1 min
postocclusion was calculated by dividing
the ankle pressure at 1 min postocclusion
by the maximal resting brachial pressure.
The recovery index 2 min postocclusion
was calculated similarly using the ankle
pressure at 2 min postocclusion. A recovery
index value of0.97 or greater is considered
normal. Avalue less than 0.97 is consistent
with APAF (34).
CaseDefinitions
A participant was defined as having a
history ofmyocardial infarction if the
individual met one of two criteria. The
participant either had to have reported
that a physician had diagnosed this condi-
tion or had to have ECG evidence for a
previous myocardial infarction. Similarly,
a participant was defined as having a his-
tory ofcardiac arrhythmia if the partici-
pant reported that a physician had ever
diagnosed this condition, or ifthe partici-
pant had ECG evidence for an arrhythmia
(an irregularity ofheart rhythm including
premature ventricular contractions, pre-
mature supraventricular contractions,
ectopic beats, presence of a pacemaker,
atrial fibrillation, atrial flutter, bradycardia
[under 50/min], tachycardia [over
100/min] but excluding normal sinus
rhythm). Aparticipant was defined as hav-
ing hypertension if one of the following
three criteria was satisified: a) a self-
reported history ofphysician-diagnosed
hypertension; b) the lowest oftwo brachial
artery systolic pressure readings taken
while the participant was in sitting posi-
tion exceeded 140 mm Hg (this is also the
case definition for current systolic hyper-
tension); or c) the lowest of two brachial
artery diastolic pressure readings taken
while the participant was in sitting posi-
tion exceeded 90 mm Hg (this is also the
case definition for current diastolic hyper-
tension). A participant was defined as
having APAF ifeither the resting index,
the recovery index 1 min postocclusion, or
the recovery index 2 min postocclusion
was less than 0.97 in either leg. Finally,
angina was defined as a self-reported his-
tory of physician-diagnosed angina.
Participants were excluded from an analy-
sis ifthey could not recall whether they
had the disease of interest, if the self-
reported onset of the disease of interest
preceded the date offirst exposure to sub-
stances contaminated with TCDD, or if
the examination or test was not performed
on the participant.
Analysis ofData
To evaluate the association between
TCDD exposure and each of the cardio-
vascular outcomes and to evaluate for the
presence ofparticipation bias, unadjusted
odds ratios (OR) were calculated and
tested for significance using a chi-square
test for association.
To evaluate the association between
TCDD exposure and each of the cardio-
vascular outcomes of a priori interest
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(myocardial infarction, angina, arrhythmia,
hypertension, current systolic hypertension,
current diastolic hypertension, APAF),
logistic regression analyses were performed.
The confounders that were examined in
the regression analyses are described in
detail elsewhere (29) and included years
since last occupational TCDD exposure,
age, race, gender, alcohol consumption his-
tory, employment at the NewJersey versus
Missouri plant, body mass index (weight in
kilograms divided by height squared in
meters [BMI]), use of antihypertensive
medications during the 2 weeks preceding
the physical exam, cigarette consumption
history, current diabeties, serum triglyc-
eride concentration, serum total cholesterol
concentration, serum HDL cholesterol
concentration, family history ofheart dis-
ease, occupational exposure to agents asso-
ciated with cardiovascular effects (carbon
monoxide, methylene chloride, lead, and
carbon disulfide), and presence ofpedal
edema on physical exam.
In each model, the linearity assumption
was checked for all continuous variables.
Variables found to be nonlinearwere strati-
fied based on a priori cutpoints. Variables
determined to be nonlinear in one or more
models included BMI, triglyceride, HDL
cholesterol, lipid-adjusted TCDD, half-
life-extrapolated lipid-adjusted TCDD,
and unadjusted TCDD.
Separate regression analyses were
conducted using lipid-adjusted serum
TCDD concentrations, half-life-extrapolated
lipid-adjusted serum TCDD concentrations,
or unadjusted serum TCDD concentrations.
The half-life-extrapolated lipid-adjusted
TCDD concentration is the estimated
TCDD concentration when occupational
TCDD exposure ceased and was calculated
as described previously (35) to reflect the 7-
year estimated half-life ofthe serum TCDD
concentration (36). Because findings were
similar for the analyses using the three dif-
ferent TCDD measurements, we report
only the models using the lipid-adjusted
TCDD concentrations. The workers were
stratified into two groups based on lipid-
adjusted serum TCDD concentrations: the
quartilewith theworkers havingthehighest
TCDD concentrations (238-3400 pg/g of
lipid), and the three quartiles ofworkers
with lower serum TCDD concentrations
(< 138 pg/g lipid). Eight workers were
exduded from these analyses because serum
TCDD concentrations were not obtained.
OR are provided, indicating the risk for the
outcome of interest among each group of
exposed workers compared to that for the
unexposed referent group.
Potential confounders were retained in
the final model ifthey created a meaningful
difference in the coefficient ofthe exposure
variable (more than a 15% difference) or if
they were statistically significant for the
outcome (p<0.05). No significant interac-
tions with TCDD exposure were observed.
All models appeared to have adequate fit
(37). All analyses were carried out using
SAS procedures (SAS Institute, Cary, NC).
Results
Ofthe 586 workers at the two plants who
were eligible for the study, 400 (68.3%)
were living and could be located. A total of
142 (24.2%) workers were deceased and 44
(7.5%) could not be located. All 400 work-
ers from the two plants whowere living and
could be located were invited to participate
in the study; 281 (70%) were examined. A
total of938 referents were invited to partic-
ipate in the study, ofwhom 260 (28%)
were examined.
Descriptive information on the study
cohort is provided in Table 1. Workers
were found to have a statistically signifi-
cantly elevated mean serum lipid-adjusted
TCDD concentration (worker, 220 pg/g
lipid [range, not detected, 3400 pg/g lipid;
median, 68 pg/g lipid]; referents, 7 pg/g
lipid [range, not detected, 20 pg/g lipid];
p<0.001). Half-life-extrapolated lipid-
adjusted serum TCDD concentrations
were also elevated among workers (mean,
1900 pg/g lipid; median, 476 pg/g lipid).
Overall, there were no statistically signifi-
cant differences or a consistent pattern of
differences between workers and referents
for any demographic characteristics (age,
race, gender, education, income) except for
alcohol-years (alcohol-years are the average
number ofalcoholic drinks consumed per
day multiplied by the number of years
alcohol was consumed) . Referents were
found to have a statistically significantly
higher mean lifetime alcohol consumption
(workers, 41.4 alcohol-years; referents,
Table 1. Characteristics ofthe study population by lipid-adjusted serum TCDD group.
Referents Workerswith lowerserum TCDDa Workerswith higher serum TCDDb All workers,
(n=260) (n=208) (n=65) (n=281)c
Mean age, years (SD) 56.0(10.5) 53.2 (9.6)* 61.4(10.0)* 55.4(10.3)
White, % 88.9 88.0 92.3 88.9
Male, % 93.5 93.3 100* 95.0
Current drinker, % 63.1 64.4 63.1 64.4
Formerdrinker, % 23.9 27.9 26.2 27.1
Mean alcohol-years (SD) 62.1 (115.1) 40.9(64.3)* 41.4 (60.3)* 41.4(63.4)*
Current smoker, % 32.3 37.5 23.1 33.8
Former smoker, % 46.5 41.4 55.4 44.5
Mean pack-years (SD) 29.0 (32.4) 26.4(28.3) 24.5(24.8) 25.8 (27.3)
Plant 1, % 0 76.9* 83.1* 79.0*
Body mass index >29, % 28.9 28.4 30.8 29.2
Use of antihypertensive medication, % 21.9 19.2 20.0 20.6
Family history of heart disease, % 50.6 51.9 53.2 52.5
Family history of hypertension, % 47.1 48.5 36.9 45.8
Current diabetic, % 6.2 8.2 15.4* 9.6
Serum triglyceride2 250 mg/dl, % 7.3 8.2 6.2 7.5
Serum HDL >35 mg/dl, % 86.9 84.6 80.0 82.9
Serum total cholesterol .240 mg/dl, % 32.3 37.5 24.6 33.8
Mean serum lipid adjusted TCDD, pg/g lipid (SD) 7 (2) 59(59)* 730(675)* 220(434)*
"Serum TCDD <238 pg/g lipid. bSerum TCDD .238 pg/g lipid. cThe number of all workers is greater than the sum of the two subsets of workers (workers with lower and
higher serum TCDD concentrations) because the group of all workers includes the eight workers for whom serum TCDD was not measured. *p<0.05 unexposed referent
group versus the group of exposed workers.
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62.1 alcohol-years), which was attributed to
seven referents with extremelyhigh alcohol-
year values. This was not considered an
important difference because alcohol-years
was found not to be aconfounder in anyof
the analyses. Finally, workers in the quar-
tile with the highest serum TCDD con-
centrations were older and had a higher
prevalence ofdiabetes mellitus compared
to the referent group.
Table 2 provides the results of the
unadjusted analyses ofthe cardiovascular
outcomes among workers and referents.
Workers were not found to have a signifi-
candyelevated risk for any ofthe cardiovas-
cular outcomes. Findings were similarwhen
workers, stratified by lipid-adjusted serum
TCDD concentration, were compared with
the referent group.
Table 3 provides the results oflogistic
regression analyses for each ofthe cardio-
vascular outcomes. These analyses revealed
that even after controlling for important
confounders, TCDD exposure was not
associated with an increased risk for
myocardial infarction, angina, arrhythmia,
hypertension, current systolic hyperten-
sion, current diastolic hypertension, or
APAF. Even when the models were sepa-
rately fitted with various parametric rela-
tionships for the lipid-adjusted serum
TCDD concentration (linear, quadratic,
log-transformed), TCDD was not signifi-
candy associated with any ofthe outcomes
of interest. Furthermore, the findings for
angina, current diastolic hypertension, and
APAF are similar even after eliminating
those variables (diabetes, triglycerides, and
HDL cholesterol) found bysome investiga-
tors to be possibly affected by TCDD
exposure (i.e., potential intermediate vari-
ables). We found that age, gender, BMI,
cigarette smoking, current diabeties, and a
family history ofheart disease were signifi-
cant risk factors for two or more ofthese
outcomes ofinterest.
Discussion
Our data do not support an association
between long-term, high-dose TCDD
exposure and any ofseveral adverse cardio-
vascular outcomes. Although our data are
consistent with other cross-sectional med-
ical studies and some mortality studies of
TCDD-exposed populations, data from
four mortality studies suggest that TCDD
exposure may be associated with an
increased risk for cardiovascular disease
mortality (15-18).
Two mortality studies of workers
employed at pesticide-producing chemical
plants showed positive dose-response
associations between TCDD exposure and
cardiovascular disease mortality (16,18).
Flesch-Janys et al. (16) found significant
trends between TCDD exposure and both
cardiovascular disease (codes 390-459 from
the International Classification ofDisease,
9th revision [ICD-9]) and ischemic heart
disease mortality (ICD-9 codes 410-414).
Those with the highest predicted half-life-
extrapolated serum TCDD concentrations
(345-3890 pg/g lipid) had the highest
risk ratio (RR) for cardiovascular disease
(RR= 1.96; 95% confidence interval
[CI]= 1.15, 3.34) and ischemic heart disease
(RR=2.48; 95% CI= 1.32, 4.66). Hooiveld
et al. (18) also found that those with the
highest predicted half-life-extrapolated
serum TCDD concentrations (121.5 pg/g
lipid or higher) had the highest risk for cir-
culatory system disease mortality (RR=2.44;
95% CI= 1.34, 4.46) and ischemicheart dis-
ease mortality (ICD-9codes not provided)
(RR=3.70; 95% CI= 1.75, 7.80).
A study ofAir Force personnel (the
Ranch Hands Study) responsible for spray-
ingAgent Orange, a TCDD-contaminated
herbicide mixture, in Vietnam from 1962
to 1971 found an elevated risk for circula-
tory system disease mortality among non-
flying enlisted personnel (ICD-9codes not
provided) (standardized mortality ratio
[SMR] = 1.6; 95% CI= 1.05, 2.35) but not
among the entire cohort in the Ranch
Hands Study (SMR= 1.05; 95% CI=0.76,
1.42) compared to a nonexposed compari-
son group of Air Force veterans (17).
Among the personnel in the Ranch Hands
Study, the nonflying enlisted personnel
had the highest current serum dioxin
concentrations (27).
Another mortality study ofa TCDD-
exposed cohort found an increased risk for
cardiovascular disease (15). Bertazzi et al.
(15) studied the mortality ofcitizens in the
Seveso region ofItaly exposed to TCDD
after an explosion at a trichlorophenol plant.
For this study the Seveso region was divided
into three zones named zones A, B, and R.
Zone A had the highest TCDD contamina-
tion, zone R the lowest. Zone A males and
females had an increased risk ofdeath from
nonmalignant disease ofthe circulatory sys-
tem (ICD-9 codes 390-459) (males:
SMR= 1.75, 95% CI= 1.0-3.2; females:
SMR= 1.89, 95% CI = 0.8-4.2). Zone R
females also had a slightly increased risk of
death from nonmalignant disease ofthe cir-
culatory system (SMR= 1.15; 95% CI=
1.0-1.3). In addition, Zone R males had a
statistically significant increased risk for
death from chronic ischemic heart disease
(ICD-9codes 412, 414) (SMR= 1.61; 95%
CI = 1.2-2.2) and Zone R females from
hypertensive heart disease (ICD-9 codes
401-405) (SMR= 1.62; 95% CI= 1.0-2.8).
Zone B residents did not have an increased
risk ofdeath from anydisease ofthe circula-
tory system. Because the increased risk for
cardiovascular disease mortality was
observed principally within the first 5 years
after the explosion, Bertazzi et al. (15)
emphasized the role ofdisaster-related stres-
sors. However, in light ofthe findings of
Flesch-Janys et al. (16) and the Ranch
Hands Study (17), the suggestion that stress
was responsible for the Seveso findings
needs to be reconsidered.
Several mortality studies ofTCDD-
exposed occupational cohorts did not find
a significantly elevated risk for cardiovascu-
lar disease (19-22). However, comparison
of findings across studies is difficult
because oflack ofconsistency in the types
of cardiovascular diseases that were
reported. Furthermore, some of these
studies are limited by small sample size
(19,20) and lack of detailed exposure-
response analyses (20,22). On the other
hand, it should be noted that the SMRs for
cardiovascular disease approached or
exceeded 1.00 in many of these studies
(19,21,22), suggesting the absence of a
healthy worker effect. Because employed
workers are healthier than the general pop-
ulation, the SMR for cardiovascular disease
in employed populations is generally lower
than 1 (38,39), although this differential
disappears with longer follow up (39). The
absence ofa healthy worker effect in these
TCDD-exposed cohorts may suggest a pos-
sible association between TCDD exposure
and cardiovascular disease.
Several cross-sectional medical studies
have also examined the association between
TCDD exposure and effects on the cardio-
vascular system (23-27). Statistically sig-
nificant associations were found only in the
U.S. Air Force Ranch Hands Study (27).
Although the overall conclusion from the
study was that there was no apparent asso-
ciation between cardiovascular disease and
TCDD exposure, an elevated risk was
observed for peripheral pulse abnormalities
offour leg arteries, medical record-verified
hypertension, and nonspecific ST- and T-
wave changes on ECG. It should be noted
that the personnel participating in the U.S.
Air Force Ranch Hands Study had lower
serum TCDD concentrations (median
12.5 pg/g lipid, range 0-618 pg/g lipid)
(27) than the workers we studied. The
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Table 3. Parameter estimates from adjusted logistic regression models formyocardial infarction, angina, arrythmia,
hypertension, andAPAF.
Beta SE OR 95%07 Cl
Myocardial infarctiona
Workers with serum TCDD < 238 pg/g lipid
Workers with serum TCDD 238 pg/g lipid
Age, per year
Perpack-year
Current alcohol drinker
Former alcohol drinker
Family history ofheart disease
Employed at NewJersey plant
No. observations, 521
Hosmer and Lemeshow Goodness-of-Fit Test
Angina
Workers with serum TCDD <238 pg/g lipid
Workers with serum TCDD 238 pg/g lipid
Age (greaterthan 55years)
HDL cholesterol (greaterthan 35 mg/dl)
Current diabeties
Family history of heart disease
No. observations, 522
Hosmer and Lemeshow Goodness-of-Fit Test
Arrhythmiaa
Workers with serumTCDD <238 pg/g lipid
Workers with serumTCDD .238 pg/g lipid
Age (greaterthan 55years)
No. observations, 527
Hosmer and Lemeshow Goodness-of-Fit Test
Hypertensionb
Workers with serum TCDD <238 pg/g lipid
Workers with serum TCDD 238 pg/g lipid
Age, per year
BMI (greaterthan 29)
Male gender
Family history ofhypertension
No. observations, 506
Hosmer and Lemeshow Goodness-of-Fit Test
Current systolic hypertension
Workers with serum TCDD < 238 pg/g lipid
Workers with serum TCDD 238 pg/g lipid
Age, per year
BMI (greaterthan 29)
Caucasian race
Family history ofhypertension
No. observations, 506
Hosmer and Lemeshow Goodness-of-Fit Test
Current diastolic hypertension
Workers with serum TCDD < 238 pg/g lipid
Workers with serumTCDD 238 pg/g lipid
Triglyceride (>250 mg/dl)
BMI (greaterthan 29)
Currentalcohol drinker
Former alcohol drinker
Male gender
No. observations, 514
Hosmer and Lemeshow Goodness-of-Fit Test
Abnormal peripheral arterial flow
Workers with serumTCDD < 238 pg/g lipid
Workers with serumTCDD 238 pg/g lipid
Age, per year
Per pack-year(square root)
Serum cholesterol (per mg/mi)
Current cigarette smoker
Formercigarette smoker
Caucasian race
Current diabeties
No. observations, 527
Hosmerand Lemeshow Goodness-of-Fit Test
0.13
0.08
0.07
0.02
-0.91
0.30
0.97
0.48
0.70
0.79
0.02
4.7 x10-3
0.57
0.57
0.36
0.68
1.14
1.09
1.07
1.02
0.40
1.35
2.63
1.61
0.29, 4.49
0.23, 5.06
1.03,1.11
1.01, 1.03
0.13,1.23
0.44,4.15
1.30, 5.33
0.43, 6.06
4.35with 8 degrees offreedom (p=0.82)
-0.06
-0.40
1.56
-0.71
1.54
1.29
0.38
0.53
0.44
0.44
0.43
0.40
0.95
0.67
4.76
0.49
4.64
3.58
0.45, 1.98
0.24,1.89
2.00,11.36
0.21, 1.16
1.99, 10.85
1.67, 7.86
10.24with 8 degrees offreedom (p=0.25)
-0.03
-0.26
0.82
0.28
0.42
0.28
0.98
0.77
2.27
0.56, 1.70
0.34, 1.78
1.31, 3.93
0.66 with 4 degrees offreedom (p=0.96)
0.29
0.05
0.06
1.03
1.16
0.47
0.21
0.30
0.01
0.21
0.46
0.20
1.34
1.05
1.06
2.81
3.20
1.59
0.89, 2.02
0.58, 1.89
1.04, 1.08
1.85, 4.28
1.29, 7.94
1.08, 2.34
11.34with 8 degrees offreedom (p=0.18)
0.09
0.18
0.11
0.92
-1.54
0.69
0.26
0.34
0.01
0.25
0.38
0.24
1.09
1.20
1.12
2.51
0.22
2.00
0.65, 1.83
0.61, 2.34
1.09, 1.15
1.52, 4.13
0.10,0.45
1.24, 3.23
5.83 with 8 degrees offreedom (p=0.67)
0.30
-0.03
0.78
0.77
1.04
0.60
1.68
0.22
0.33
0.36
0.22
0.43
0.47
0.74
1.35
0.97
2.19
2.16
2.83
1.82
5.35
0.88, 2.09
0.51, 1.87
1.09, 4.40
1.40, 3.32
1.21, 6.62
0.73, 4.56
1.23, 23.28
1.51 with 7 degrees offreedom (p=0.98)
-0.15
0.17
0.04
0.22
7.1xlO-3
0.80
0.40
-1.00
0.93
0.28
0.39
0.01
0.06
3.0x10-3
0.69
0.63
0.41
0.39
0.86
1.19
1.04
1.24
1.01
2.23
1.49
0.37
2.55
0.50, 1.51
0.55, 2.55
1.01, 1.07
1.11, 1.39
1.00,1.01
0.58, 8.59
0.43, 5.15
0.17, 0.82
1.19, 5.47
5.90 with 8 degrees offreedom (p=0.66)
half-life-extrapolated serum TCDD concen-
trations were also lower (median among per-
sonnel in the Ranch Hands Study having
dioxin concentrations above background-
130 pg/glipid; range notprovided) (40).
The Ranch Hands Study found that
among the participants with a normal pulse
examination in 1985, those with a current
serum lipid-adjusted TCDD concentration
greater than 10 pg/g lipid in 1992 had
increased risk for abnormalitiesof the
femoral pulse (RR= 3.35; 95% CI = 0.95,
11.8), popliteal pulse (RR=4.86; 95%
CI= 1.80, 13.10), dorsalis pedis pulse
(RR= 1.70; 95% CI =0.96, 2.99), and
posterior tibial pulse (RR = 2.80; 95%
CI= 1.39, 5.65) (27). In contrast, our
study ofworkers who had higher serum
TCDD concentrations compared to the
those in the Ranch Hands Study did not
find evidence ofperipheral arterial disease.
One explanation for this difference in find-
ings may involve the techniques used to
examine the lower extremity arteries. Our
study used pressure indices whereas the
Ranch Hands Study used Doppler wave-
form morphology. Pressure indices are the
preferred noninvasive test for assessing the
presence ofperipheral arterial disease (41).
Although Doppler waveform morphology
can be useful as a supplemental test,
interpretation of the test can be difficult
and is prone to error due to Doppler equip-
ment problems, poor operator technique,
and certain pathologic and physiologic
conditions (42). In future studies, con-
sideration should be given to including
both techniques for assessing peripheral
arterial disease.
In addition, the Ranch Hands Study
found a significant association between
current lipid-adjusted TCDD concentra-
tion and both medical record-verified
hypertension (RR for a 2-fold increase in
TCDD = 1.14; 95% CI = 1.02, 1.28) and
presence of nonspecific ST- and T-wave
changes on ECG (RR for a 2-fold
increase in TCDD = 1.20; 95% CI = 1.03,
1.40) (27). Several other cardiovascular
outcomes examined in the Ranch Hands
Study were found not to be associated
with serum lipid-adjusted TCDD con-
centration. These included hypertension
detected on examination, medical record-
verified myocardial infarction, medical
record-verified heart disease (not further
specified), and other types of ECG
abnormalities (excluding nonspecific
ST-and T-wave changes). The U.S. Air
Force Ranch Hands Study, therefore,
does not provide definitive conclusions
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Beta, parameter estimate. SE, standard error; pack-year, smoking one pack of cigarettes dailyfor 1 year. &Includes
those with self-reported and/or ECG diagnosis of the outcome. bincludes those meeting any of the three criteria:
self-reported hypertension, current systolic hypertension, orcurrent diastolic hypertension.
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because of inconsistent findings for
related outcomes.
No statistically significant associations
were observed in any of the other cross-
sectional medical studies that reported
cardiovascular outcomes (23-26). It
should be noted that these other studies
may have been limited by small sample
size, and except for the study by Zober et
al. (26), lack ofdetailed exposure-response
analyses. Among 204 male 2,4,5-tri-
chlorophenoxyacetic acid (2,4,5,-T) pro-
duction workers, Suskind and Hertzberg
(23) found no increased risk for self-
reported hypertension, self-reported coro-
nary artery disease, ECG findings, or
atherosclerotic changes (not specified) on
chest X-ray. Similarly, when Moses et al.
(24) examined 116 male 2,4,5-T produc-
tion workers with chloracne and compared
them with workers not affected by chlor-
acne, she found no increased risk for self-
reported angina or self-reported myocardial
infarction and no difference in the physical
examination ofthe cardiovascular system.
Bond et al. (25) found no increased associ-
ation with self-reported hypertension
among 27 workers involved in the produc-
tion ofTCP or among 87 workers involved
in 2,4,5-T production. Finally, Zober et al.
(26) did not find increased morbidity due
to ischemic heart disease or other disorders
ofthe circulatory system among 158 men
who were exposed to TCDD after an
uncontrolled decomposition reaction
involving aTCP unit.
Cross-sectional medical studies may be
less suitable for investigating severe or fatal
disease such as cardiovascular disease
because affected individuals often are not
capable of participating in this type of
study (43). We considered this participa-
tion bias as a possible explanation for why
our study and other cross-sectional med-
ical studies did not find an association
between TCDD exposure and cardiovas-
cular disease morbidity. For this explana-
tion to be true, one would expect to see
elevated cardiovascular disease mortality
among the cohorts studied. The plants
studied by Suskind and Hertzberg (23),
Moses et al. (24), Bond et al. (25), and
the two plants described here were
included in a large cohort mortality study
of U.S. workers involved in the produc-
tion ofTCDD-contaminated substances
(21). This study by Fingerhut et al. (21).
did not find an elevated risk for heart dis-
ease mortality (ICD-9 codes 390-398,
402-404, 410-414, 420-429) (SMR=0.96,
95% CI =0.87-1.06), even among those
with the highest durations of exposure
(SMR=0.87 among those with 15 or more
years ofexposure) (44). Findings were sim-
ilar for ischemic heart disease (ICD-9codes
410-414) (SMR= 103) (44). Among
workers at the two plants we studied, the
SMRs for heart disease and ischemic heart
disease were 1.07 and 1.06, respectively
(44). These results suggest that participa-
tion bias may not be responsible for the
findings in our study or in several other
cross-sectional studies.
Furthermore, to assess the potential
magnitude of participation bias in our
study, a telephone interview was attempted
with all the workers who would not consent
to an examination, a 10% random sample
ofthe referents who refused all participa-
tion, and all ofthe referents who provided
lifetime occupational histories but refused to
be examined. Ofthe 115 nonconsenting
workers (excluding 2 who resided outside
the United States and 2 who died between
the first and this subsequent vital status
determination) and 129 nonconsenting
referents, 68 (57%) and 100 (78%), respec-
tively, agreed to be interviewed by tele-
phone. These individuals were asked
questions similar to those asked in our med-
ical study. The proportions ofexamined and
nonconsenting workers reporting histories
ofmyocardial infarction or angina were not
statistically significantly different (Table 4).
Similar results were found for the referents
(Table 5). These results further suggest that
participation bias may not be responsible for
our studyfindings. We were unable to com-
pare hypertension or cardiac arrhythmia
because the questions asked about these
conditions in the medical study differed
from those asked in the telephone interview.
A possible limitation in this study is the
low statistical power for examining some of
the outcomes of interest. Although our
study had sufficient power (80% or more)
to detect a 1.5-fold elevation in risk for car-
diac arrhythmias, hypertension, and APAF,
our study had low power (approximately
50%) for detecting a similar elevation in
risk for myocardial infarction and angina.
Although cross-sectional medical studies
provide little evidence to support an associ-
ation between TCDD exposure and cardio-
vascular disease, these studies have found
associations with several risk factors for car-
diovascular disease. Among the risk factors
found to be associated with TCDD expo-
sure were decreased HDL cholesterol serum
concentrations (27,29), increased serum
triglyceride concentrations (27-29), and
glucose intolerance (30). There is some ani-
mal evidence to suggest that a TCDD-
induced metabolic imbalance can lead to
some ofthese risk factors. Enan et al. (45)
found that TCDD-exposed guinea pigs
have reduced glucose-transporting activity
in the plasma membranes ofadipose tissue
and pancreas. In adipose tissue, reduced
transmembrane glucose transport leads to
suppressed lipoprotein lipase activity, and
in the pancreas, to suppressed insulin pro-
duction and release. These effects can lead
to hypertriglyceridemia (lipoprotein lipase
is responsible for metabolizing triglycerides
absorbed from the gut) and glucose intoler-
ance (insulin is needed for the metabolism
ofglucose), respectively, both ofwhich are
risk factors for cardiovascular disease. In
Table 4. Comparison of self-reported history of physician-diagnosed myocardial infarction and angina between
examined and nonconsenting workers.
Number of examined Number of nonconsenting
workers workers
Outcome Yes No Excludeda Yes No Excludeda Unadjusted OR(95% Cl)
Myocardial infarction, 25 254 3 7 61 0 0.86(0.33, 2.29)
self-reported
Angina, self-reported 24 256 1 2 66 0 3.09(0.68, 12.54)
&Participants were excluded from the analysis ifthey could not recall whetherthey had the disease of interest.
Table 5. Comparison of self-reported history of physician-diagnosed myocardial infarction and angina between
examined and nonconsenting referents.
Number of examined Number ofnonconsenting
referents referents
Outcome Yes No Excludeda Yes No Excludeda Unadjusted OR (95% Cl)
Myocardial infarction, 14 254 2 9 91 0 0.58(0.23, 1.51)
self-reported
Angina, self-reported 22 237 1 6 94 0 1.45(0.54,4.15)
&Participants were excluded from the analysis ifthey could not recall whetherthey had the disease of interest.
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support of this hypothesis, two animal
studies have shown that TCDD causes
suppressed lipoprotein lipase activity
(4,46). Because the origin and metabolism
of HDL is not as well understood com-
pared with that ofother lipoproteins, the
mechanism by which TCDD affects HDL
metabolism cannot be determined at
this time.
In conclusion, our study found that
workers with high occupational TCDD
exposure at least 15 years earlier, many of
whom continued to have persistently
elevated TCDD body burdens, had no
significantly increased riskfor anyofthe car-
diovascular outcomes we investigated. Our
findings are consistent with those ofother
cross-sectional medical studies ofTCDD-
exposed individuals. Although several mor-
tality studies ofTCDD-exposed cohorts
found an increased risk for cardiovascular
disease mortality, other mortality studies
did not have similar findings. The dataavail-
able do not provide definitive conclusions
but indicate that further examination ofthe
association between TCDD exposure and
cardiovascular disease shouldbepursued.
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